Synopsis: After a special meeting, the Japanese drug reviewers ruled that existing data didn’t support an approval and are therefore seeking additional…
December 2021
-
-
AgrochemicalsGlobal Market
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
by adminby adminSynopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
-
Summary : Minim, Inc. the creator of intelligent networking products under the Motorola brand, announced that Sean Doherty will be transitioning from…
-
CompaniesNovartisRegulatoryU.S FDA
Novartis Cosentyx® Receives FDA Approval for the Treatment of Children and Adolescents with Enthesitis-Related Arthritis and Psoriatic Arthritis
by adminby adminSummary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
-
Synopsis : – Slalom Launch Center to help Japanese organizations accelerate cloud transformation and modernize their technology services Amazon Web Services…
-
AgrochemicalsIndiaLaunch
BDR Pharma launches India’s First Generic Pazopanib to Treat Various Cancer .
by adminby adminSynopsis : Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma…
-
AgrochemicalsIndia
Government Approves PLI Scheme to Promote Domestic API Production.
by adminby adminSummary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…
-
AgrochemicalsGlobal MarketLaunch
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
by adminby adminSummary – BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced…
-
LaunchPharma Science & Research
MedMira Inc. Announces to Launch VYRA™ CoV2Flu Rapid Antigen Rapid Test
by adminby adminSummary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed…
-
RegulatoryU.S FDA
FDA IND Application Clearance to Hepion Pharma for its CRV431 in the Treatment of Liver Cancer
by adminby adminSummary – New IND Expands Liver Disease Pipeline for CRV431 IND Clearance Allows CRV431 to Move Directly into Phase 2 for Hepatocellular…